AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 45 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,000 | -69.6% | 4,000 | -80.1% | 0.00% | – |
| Q3 2022 | $23,000 | +475.0% | 20,087 | +1155.4% | 0.00% | – |
| Q1 2022 | $4,000 | -73.3% | 1,600 | -59.3% | 0.00% | – |
| Q4 2021 | $15,000 | +36.4% | 3,930 | +51.2% | 0.00% | – |
| Q3 2021 | $11,000 | -62.1% | 2,600 | -64.3% | 0.00% | – |
| Q2 2021 | $29,000 | +16.0% | 7,274 | +55.1% | 0.00% | – |
| Q1 2021 | $25,000 | +66.7% | 4,689 | +68.4% | 0.00% | – |
| Q4 2020 | $15,000 | +50.0% | 2,784 | +30.3% | 0.00% | – |
| Q3 2020 | $10,000 | +25.0% | 2,136 | +33.5% | 0.00% | – |
| Q2 2020 | $8,000 | -72.4% | 1,600 | -88.2% | 0.00% | – |
| Q1 2020 | $29,000 | -87.9% | 13,569 | -66.9% | 0.00% | – |
| Q4 2019 | $239,000 | +154.3% | 40,977 | +38.9% | 0.00% | – |
| Q3 2019 | $94,000 | -62.2% | 29,492 | -50.3% | 0.00% | – |
| Q2 2019 | $249,000 | +2666.7% | 59,309 | +11283.7% | 0.00% | – |
| Q3 2018 | $9,000 | – | 521 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $36,580,000 | 71.47% |
| WEDBUSH SECURITIES INC | 98,489 | $313,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 29,536 | $94,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 72,296 | $230,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 114,211 | $363,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $191,000 | 0.00% |
| Baker Brothers Advisors | 99,600 | $317,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 8,129 | $26,000 | 0.00% |
| Squarepoint Ops LLC | 40,777 | $130,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 100,089 | $318,000 | 0.00% |